A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Clinical trial NCT04626674 · RECRUITING
Trial details
- NCT number
- NCT04626674
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2027-12-31
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.